title: [Radionuclide diagnosis of tricuspid regurgitation as a method of estimating the significance of tricuspid insufficiency with concurrent mitral valve disease].
abstract: A mitral valve replacement without simultaneous correction of a concomitant tricuspid regurgitation aggravates remote postoperative results. Nowadays diagnostics of a degree of tricuspid regurgitation bases on semi-quantitative methods, which are not unequivocal criteria of a significant tricuspid insufficiency. The aim of the study was to investigate diagnostic usefulness of a radioisotopic method of determination significant tricuspid insufficiency. The study group consisted of 35 patients with rheumatic mitral valve disease and tricuspid regurgitation (30 females, 5 males) at a mean age of 55 years qualified for operative treatment. Physical and noninvasive examinations were performed in all patients: chest X-ray (relative heart volume--RHV) and echocardiographicy (tricuspid regurgitation and right ventricle pressure). Final determination of a significant tricuspid insufficiency based on intraoperative diagnosis. The radioisotopic method relies on first pass technique with a determination of a tricuspid regurgitation index (TRI) and a right ventricular ejection fraction. Intraoperatively the patients were divided into two groups: with significant tricuspid regurgitation--21 patients and without--14 patients. Statistically significant differences, considering clinical and echocardiographic assessment between the two groups were noticed. The TRI index did not differentiate two groups. Noninvasive parameters that could affect diagnosis of significant tricuspid regurgitation were proved by a logistic regression analysis. Among them the TRI Index could have a separate value.
  
  
  CONCLUSIONS
  Presented radioisotopic method of determination a degree of tricuspid regurgitation with the new TRI Index is of value in diagnosing significant tricuspid insufficiency when assessed with other noninvasive parameters. Estimation of a clinical usefulness of the method needs further investigation and bigger study group.
authors.affiliation: II Kliniki Wad Serca, Instytut Kardiologii w Warszawie.
authors.forename: I
authors.initials: I
authors.lastname: Rawczyńska-Englert
authors.forename: T
authors.initials: T
authors.lastname: Hryniewiecki
authors.forename: S
authors.initials: S
authors.lastname: Konieczna
authors.forename: B
authors.initials: B
authors.lastname: Suwalski
authors.forename: A
authors.initials: A
authors.lastname: Biederman
authors.forename: J
authors.initials: J
authors.lastname: Nowicka
authors.forename: E
authors.initials: E
authors.lastname: Orłowska-Baranowska
authors.forename: M
authors.initials: M
authors.lastname: Nyznyk
authors.forename: A
authors.initials: A
authors.lastname: Bieganowski
authors.forename: E
authors.initials: E
authors.lastname: Gosiewska-Marcinkowska
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D011300:Preoperative Care; D011877:Radionuclide Imaging; D012214:Rheumatic Heart Disease / Q000150:complications; D014262:Tricuspid Valve Insufficiency / Q000150:complications* / Q000000981:diagnostic imaging* / Q000601:surgery